eMedicine Specialties > Pediatrics: General Medicine > Endocrinology
Diabetes Insipidus
Updated: Feb 6, 2009
Introduction
Background
The word diabetes is derived from the Greek verb diabainein, which means to stand with legs apart (as in urination) or to go through. Insipidus comes from a Latin word meaning without taste. In contrast to diabetes mellitus (DM), which describes the excretion of sweet urine, diabetes insipidus (DI) describes the passing of tasteless urine because of its relatively low sodium content.
Nephrogenic diabetes insipidus (NDI) reached North America in 1761 and was carried by Ulster Scots who arrived in Nova Scotia, Canada, on a ship named Hopewell.1 Scottish folklore reports the existence of the disease in Scotland before 1761. According to legend, a gypsy woman traveling with her thirsty son is denied water by a housewife. The gypsy woman curses the housewife, causing the housewife's sons to crave water while condemning her daughters to pass the curse on to future generations.
Pathophysiology
The basis of water loss in diabetes insipidus is distinct from water loss caused by diabetes mellitus. The renal tubular collecting ducts are unable to concentrate urine secondary to vasopressin deficiency or resistance. The collecting duct concentrates urine by reabsorbing water, a function controlled by the posterior pituitary gland via secretion of vasopressin or antidiuretic hormone (ADH). Reabsorption of sugars, amino acids, and virtually all electrolytes is completed by the time the urine has reached this segment of the nephron. Consequently, the inability to conserve water by reabsorption in the collecting duct depletes body water but leaves sodium unaffected. The net result is an extremely diluted, increased urine output resulting in hypernatremia. Polydipsia follows, as the thirst mechanism urges replenishment of body water.
Secretion of vasopressin occurs in the posterior pituitary gland and is regulated at the paraventricular and supraoptic nuclei, which sense changes in osmolality. Destruction of the paraventricular or supraoptic nuclei or of the posterior pituitary by tumor, pressure, or surgical ablation results in decreased vasopressin secretion and central diabetes insipidus (CDI). Alternatively, diabetes insipidus may be idiopathic or inherited either as an autosomal dominant or as an autosomal recessive trait (locus 20p13).
Nephrogenic diabetes insipidus arises from defective or absent receptor sites at the cortical collecting duct segment of the nephron (X-linked, vasopressin V2 receptor deficiency, locus Xq28) or defective or absent aquaporin, the protein that transports water at the collecting duct (autosomal recessive, locus 12q13). The X-linked variety of nephrogenic diabetes insipidus (NDI) accounts for about 90% of all such cases.
As a consequence of one of these defects, the ducts do not appropriately respond to vasopressin. Normally, vasopressin is transported in the blood to receptor sites on the basolateral surface of the collecting duct membrane. Through a G protein–adenylate cyclase coupling, activation of the vasopressin receptor increases cyclic adenosine monophosphate (AMP) production and stimulates protein kinase A, leading to increased recycling of the protein aquaporin in the plasma membrane.
In the presence of vasopressin stimulus, exocytic insertion of aquaporin into the apical, or luminal, surface of the tubule cell occurs. Aquaporin enhances water entry into the cell from the lumen. Absence of the vasopressin receptor does not allow this process to take place, causing inhibition of water uptake and polyuria. Alternatively, defective or absent aquaporin impairs the process in the presence of normal V2 receptors.
Frequency
United States
Tumors, infiltrative lesions, malformations, and neurosurgical procedures are the most common causes of central diabetes insipidus. Of the genetic etiologies, the overall incidence in the general population is estimated to be 3 cases per 100,000 population (0.003%). The male-to-female ratio is 60:40. X-linked nephrogenic diabetes insipidus is very rare, although it exceeds the recessive variety by a ratio of 9:1. The mutation for males is 4 cases per million population.
Mortality/Morbidity
Dehydration results from an inability to reabsorb free water at a site distal to electrolyte reabsorption. Any patient unable to continuously replace water loss is vulnerable to dehydration, especially in warm weather when insensible water loss through perspiration and respiration substantially increases risk. Electrolyte abnormalities are caused by the loss of urinary free water, which produces hyperosmolar dehydration, leading to hypernatremia, hyperchloremia, and prerenal azotemia. Diminished blood volume increases blood viscosity and the risk of sludging and thrombosis.
Failure to thrive occurs because of the patient's constant thirst conferring a sense of fullness that offsets the sense of hunger. The affected individual eats less than necessary for normal growth. Seizures are a consequence of the electrolyte abnormalities introduced in the CNS by severe hypernatremia and hyperosmolar dehydration. Mental retardation results from the damage to the CNS caused by severe hyperosmolarity, seizures, and potential hypoxia, all of which are thought to account for the frequent occurrence of mental retardation. Death can occur from a hypovolemic shock or a hypernatremic seizure.
Sex
Central diabetes insipidus secondary to hypothalamic-pituitary lesions occurs at random and should, therefore, be evenly distributed between the sexes. Autosomal dominant and autosomal recessive central diabetes insipidus occur equally in both sexes. Nephrogenic diabetes insipidus caused by an X-linked mutation affects only males. Autosomal dominant and autosomal recessive forms of nephrogenic diabetes insipidus equally affect both sexes.
Age
Diabetes insipidus occurs in people of a wide age range. Children who present with autosomal recessive central diabetes insipidus are generally younger than 1 year. Children who present with autosomal dominant central diabetes insipidus are often older than 1 year. Nephrogenic diabetes insipidus forms (including X-linked, autosomal dominant, and autosomal recessive forms) develop in early infancy, often in neonates younger than 1 week.
Clinical
History
- Diagnosis of diabetes insipidus (DI) may be difficult in infants and children because of nonspecific presenting features (eg, poor feeding, failure to thrive, irritability). Therefore, a high index of suspicion is necessary.
- The earliest signs of diabetes insipidus include a vigorous suck with vomiting, fever without apparent cause, constipation, and excessively wet diapers from urination.
- In older infants and young children, irritability is generally due to a borderline state of dehydration coupled with hypernatremia and, sometimes, fever.
- Nocturia is common and expected because of increased urine production.
- Central diabetes insipidus (CDI) tends to suddenly develop.
Physical
- The typical examination reveals an irritable infant with a dripping wet diaper, along with detectable signs of dehydration (eg, dry mucous membranes, diminished skin turgor, decreased tearing, tachycardia). Often, skin turgor is not diminished in individuals with hypernatremic dehydration despite significant dehydration.
- In severely dehydrated patients, the pulse may be thready and rapid. Hypotension may be present because of hypovolemic shock.
- Mobile fecaliths may be palpable in the abdomen.
Causes
Diabetes insipidus is due to either (1) deficiency of vasopressin secretion by the pituitary gland (central diabetes insipidus or neurogenic diabetes insipidus) or to (2) renal tubular unresponsiveness to vasopressin (nephrogenic diabetes insipidus [NDI]).
- Nongenetic causes
- Typical injuries include head trauma, tumor, and neurosurgical procedures.
- At all ages, destructive lesions of the pituitary and/or hypothalamus are the most common cause of diabetes insipidus.
- Genetic causes
- Central diabetes insipidus with an autosomal dominant pattern inheritance is due to a mutation in the prepro-arginine vasopressin (prepro-AVP2) gene, mapped to locus 20p13.
- Central diabetes insipidus with diabetes mellitus, optic atrophy, and mental retardation (Wolfram syndrome) may be inherited in an autosomal recessive pattern (locus 4p16) or may be due to mitochondrial deletions.
- X-linked nephrogenic diabetes insipidus occurs from mutations in the antidiuretic arginine vasopressin V2 receptor (AVPR2) gene, mapped to Xq28.2,3,4
- Nephrogenic diabetes insipidus with an autosomal dominant or recessive pattern is due to mutations in the gene designated AQP2; this gene directs water channel formation in the distal membrane and has not yet been mapped.
More on Diabetes Insipidus |
Overview: Diabetes Insipidus |
| Differential Diagnoses & Workup: Diabetes Insipidus |
| Treatment & Medication: Diabetes Insipidus |
| Follow-up: Diabetes Insipidus |
| Multimedia: Diabetes Insipidus |
| References |
| Next Page » |
References
Bichet DG, Arthus MF, Lonergan M, et al. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest. Sep 1993;92(3):1262-8. [Medline]. [Full Text].
Friedman E, Bale AE, Carson E, et al. Nephrogenic diabetes insipidus: an X chromosome-linked dominant inheritance pattern with a vasopressin type 2 receptor gene that is structurally normal. Proc Natl Acad Sci U S A. Aug 30 1994;91(18):8457-61. [Medline]. [Full Text].
Wildin RS, Antush MJ, Bennett RL. Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus. Am J Hum Genet. Aug 1994;55(2):266-77. [Medline].
Faerch M, Christensen JH, Corydon TJ, et al. Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene. Clin Endocrinol (Oxf). Mar 2008;68(3):395-403. [Medline].
Alon U, Chan JC. Hydrochlorothiazide-amiloride in the treatment of congenital nephrogenic diabetes insipidus. Am J Nephrol. 1985;5(1):9-13. [Medline].
Blackett PR, Seif SM, Altmiller DH, Robinson AG. Familial central diabetes insipidus: vasopressin and nicotine stimulated neurophysin deficiency with subnormal oxytocin and estrogen stimulated neurophysin. Am J Med Sci. Nov-Dec 1983;286(3):42-6. [Medline].
Davies JH, Penney M, Abbes AP, et al. Clinical features, diagnosis and molecular studies of familial central diabetes insipidus. Horm Res. 2005;64(5):231-7. [Medline].
Garofeanu CG, Weir M, Rosas-Arellano MP, et al. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis. Apr 2005;45(4):626-37.
Leung AK, Robson WL, Halperin ML. Polyuria in childhood. Clin Pediatr (Phila). Nov 1991;30(11):634-40. [Medline].
Libber S, Harrison H, Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr. Feb 1986;108(2):305-11. [Medline].
Mulders SM, Bichet DG, Rijss JP, et al. An aquaporin-2 water channel mutant which causes autosomal dominant nephrogenic diabetes insipidus is retained in the Golgi complex. J Clin Invest. Jul 1 1998;102(1):57-66. [Medline]. [Full Text].
Pivonello R, Colao A, DiSomma C, et al. Impairment of bone status in patients with central diabetes insipidus. J Clin Endocrinol Metab. Jul 1998;83(7):2275-80. [Medline]. [Full Text].
Saborio P, Tipton GA, Chan JC. Diabetes insipidus. Pediatr Rev. Apr 2000;21(4):122-9; quiz 129. [Medline].
Soylu A, Kasap B, Ogun N, et al. Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus. Pediatr Nephrol. Dec 2005;20(12):1814-7. [Medline].
Further Reading
Keywords
diabetes insipidus, DI, hypernatremia, thirst, polydipsia, dehydration, central diabetes insipidus, CDI, nephrogenic diabetes insipidus, NDI, failure to thrive, nocturia, fecalith, Wolfram syndrome, diabetes mellitus, optic atrophy, mental retardation, hypokalemia, hypercalcemia
Overview: Diabetes Insipidus